Volume 8.
Issue 11.

The increasing challenge of antimicrobial resistance has intensified interest in biologically derived compounds with antibacterial, inflammation-modulating, and immune-regulating properties. Members of the genus Streptomyces are promising sources of structurally diverse secondary metabolites, including compounds that may have pharmaceutical and biotechnology applications. This paper evaluates the potential of Streptomyces-derived bioactive extracts through a literature-based analytical approach integrating antimicrobial activity, anti-inflammatory potential, and immunostimulatory effects. The review draws on eight supplied references addressing actinomycete natural-product diversity, antioxidant activity in a mangrove-derived Streptomyces isolate, bacterial secondary-metabolite ecology, antibacterial mechanisms, antibiotic resistance, and immune responses in aquatic organisms. A proposed experimental framework is developed to assess extract composition, antibacterial efficacy, inflammatory responses, immune stimulation, and preliminary safety within a unified evaluation system. The synthesis indicates that the three biological activities should be examined independently before their combined therapeutic value is inferred. In particular, immune stimulation cannot automatically be interpreted as protection, and antioxidant activity does not independently establish anti-inflammatory efficacy. The principal contribution is an integrated assessment framework that links chemical characterization, functional testing, and safety evaluation while identifying the evidence required for reproducible validation. Further laboratory investigations are necessary to establish potency, selectivity, mechanism of action, and translational feasibility.